1. Home
  2. HRMY vs LWLG Comparison

HRMY vs LWLG Comparison

Compare HRMY & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$33.41

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$9.58

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
LWLG
Founded
2017
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
HRMY
LWLG
Price
$33.41
$9.58
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$44.11
N/A
AVG Volume (30 Days)
718.4K
5.0M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
15.79
EPS
0.55
N/A
Revenue
$868,453,000.00
$236,855.00
Revenue This Year
$19.75
N/A
Revenue Next Year
$12.88
N/A
P/E Ratio
$60.29
N/A
Revenue Growth
21.51
147.74
52 Week Low
$25.52
$1.19
52 Week High
$40.87
$18.71

Technical Indicators

Market Signals
Indicator
HRMY
LWLG
Relative Strength Index (RSI) 54.50 42.85
Support Level $31.61 $3.46
Resistance Level $35.47 $13.65
Average True Range (ATR) 1.14 1.10
MACD 0.02 -0.13
Stochastic Oscillator 49.14 19.71

Price Performance

Historical Comparison
HRMY
LWLG

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

Share on Social Networks: